2023

Allopurinol-thiopurine versus standard thiopurine in patients with IBD

Olamkicept induction in ulcerative colitis

Upadacitinib in Crohn’s disease induction and maintenance

Tofacitinib vs oral prednisolone in moderately active UC

Upadacitinib maintenance in moderate-severe UC

Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in IBD Patients

Ritlecitinib and Brepocitinib in moderate-severe UC

Ferric carboxymaltose vs Ferrous fumarate in Anemic children with IBD

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Phase 2 trial, guselkumab in Crohn’s disease efficacy and safety at week 48